Navigation Links
Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014
Date:7/31/2014

n thousands, except per share information)(Unaudited)Three Months EndedSix Months EndedJune 30, June 30,2014201320142013Revenue:Product sales and royalty revenue

$
5,891
$
,675
$
,808
$
22,810
Non-cash royalty revenue related to sale of future royalties

4,8373,82810,6108,221License, collaboration and other revenue

17,78519,35925,86625,835Total revenue28,51333,86248,28456,866Operating costs and expenses:Cost of goods sold5,1085,01113,01516,672Research and development36,70252,23075,04097,848General and administrative9,6199,22619,54720,057Total operating costs and expenses

51,42966,467107,602134,577Loss from operations(22,916)(32,605)(59,318)

SOURCE Nektar Therapeutics
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA
3. Nektar Therapeutics Reports Financial Results for the Third Quarter of 2013
4. Nektar to Announce Financial Results for the Third Quarter of 2013 on Thursday, November 7, 2013, After Close of U.S.-Based Financial Markets
5. Nektar Reports that Partner AstraZeneca Announced European Medicines Agency Acceptance of Marketing Authorisation Application for Naloxegol
6. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2013
7. Nektar to Announce Financial Results for the Second Quarter of 2013 on Thursday, August 8, 2013, After Close of U.S.-Based Financial Markets
8. Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer
9. Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence
10. Nektar Presents Positive Preclinical Data for NKTR-214, a Novel Cancer Immunotherapy, At the 2013 American Society of Clinical Oncology Annual Meeting
11. Nektar Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... The North American dental lasers market ... to reach $90.7 million by 2019, at a CAGR of ... TOC of North America Dental Lasers Market for an analysis ... tables and figures. http://www.micromarketmonitor.com/market/north-america-dental-lasers-1771208223.html ...   Dental lasers are specifically used in ...
(Date:5/22/2015)... 2015  The U.S. Food and Drug Administration,s ... first biosimilar product approved in the ... in the contract manufacturing organization (CMO) industry, according ... geared to the production of small-molecular drugs and ... The healthcare market research publisher,s report, Biopharmaceutical ...
(Date:5/22/2015)... ROCKVILLE, Md. , May 22, 2015 /PRNewswire/ ... "RegeneRx") today announced a peer-reviewed publication of the ... study evaluating RGN-259 (RegeneRx,s preservative-free eye drops) for ... Inc.,s controlled adverse environment (CAE ® ) model.  ... and the results, which were previously disseminated by ...
Breaking Medicine Technology:North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 2North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 2Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 4
... 2012  Today ZocDoc introduces its service ... access to appointments with Greater Denver,s leading doctors, ... launch, this free service provides patients with their ... primary care doctors, obstetrician-gynecologists, dermatologists and eye doctors ...
... 22, 2012  Accident Fund Holdings, Inc., the tenth largest ... has begun the transition from Medco Health Solutions to ... Scripts leverages its advanced analytics capabilities and insights generated ... solutions that drive out waste and help improve outcomes ...
Cached Medicine Technology:Denver Patients Can Now Easily Find Doctors and Schedule Appointments Online 2Denver Patients Can Now Easily Find Doctors and Schedule Appointments Online 3Denver Patients Can Now Easily Find Doctors and Schedule Appointments Online 4Accident Fund Holdings Aims to Improve Control of Drug Utilization and Quality of Care with Change in Pharmacy Benefit Manager 2
(Date:5/26/2015)... 2015 Scientists at the University of ... help advanced mesothelioma patients benefit from immunotherapy; surgery may ... article on the new research. Click here to ... of thoracic surgery and pulmonology theorized that, because large ... system attack, immunotherapy drugs might work better if the ...
(Date:5/26/2015)... May 26, 2015 Adenna, Inc ... 1997, is excited to announce the launch of ... grade gloves made of polyethylene (PE) and approved by ... general applications. , The Enov8 glove might ... sandwiches or mixing salads but our proprietary formula and ...
(Date:5/26/2015)... Grants Pass, OR (PRWEB) May 26, 2015 ... nearly always fatal if not caught early. Melanoma is ... fresh water advocate Sharon Kleyne, the melanoma rate is ... solar radiation. While the melanoma risk for indoor tanning ... from these establishments. The most recent ban, in Pennsylvania, ...
(Date:5/26/2015)... Viejo, CA (PRWEB) May 26, 2015 ... styles for Final Cut Pro X . ... suspenseful to simple and elegantly styled text. , ... in seconds. , ProTrailer Network can easily complement any ... style desired and within seconds can make professional looking ...
(Date:5/26/2015)... Henderson, NV (PRWEB) May 26, 2015 ... is hosting a complimentary live online broadcast at 6:00pm ... and CEO and Trivedi Master™ Alice Branton welcomes the ... coworkers for a night of profound knowledge, transformation and ... The Trivedi Effect® and no previous knowledge, experience or ...
Breaking Medicine News(10 mins):Health News:Researchers Say Surgery May Restore Effectiveness of Immunotherapy for Mesothelioma, According to Surviving Mesothelioma 2Health News:Enov8® Exam Glove by Adenna® Approved by U.S. FDA 2Health News:Skin Cancer Awareness Month: Pennsylvania Ban of Teens from Tanning Salons Is Praised by Fresh Water Advocate Sharon Kleyne 2Health News:Skin Cancer Awareness Month: Pennsylvania Ban of Teens from Tanning Salons Is Praised by Fresh Water Advocate Sharon Kleyne 3Health News:Developers at Pixel Film Studios Release ProTrailer Network for Final Cut Pro X 2Health News:The Human Wellness Company Trivedi Master Wellness™ Opens a Complimentary Transformational Community Call to the Public on June 4, 2015 2Health News:The Human Wellness Company Trivedi Master Wellness™ Opens a Complimentary Transformational Community Call to the Public on June 4, 2015 3
... a serious condition that requires extensive medical intervention, ... to developing another grave condition known as Nephrogenic ... First recognized as a disease in 1997, NSF/NFD ... skin, resulting in pain, muscle weakness and difficulty ...
... and after menopause, a change thought to be due, in ... time. // ,Now, research from the University of ... retain certain memory functions. In a study in the new ... report that a group of postmenopausal women showed more brain ...
... have increased blood pressure within the remaining kidney—which could ... found in this group of donors // , reports ... Nephrology's 39th Annual Meeting and Scientific Exposition in San ... the kidney was higher in overweight donors after donation," ...
... sent letters to city, state and federal agencies claiming that ... in treating waste from animals that died of infectious diseases ... was sent to the city's sewage treatment plant. ... federal and city officials to study the issue at length. ...
... Arunachal Pradesh have rediscovered a rare medicinal plant after more ... Botanical Survey of India spotted the wild flower, Begonia Tessaricarpa, ... northeastern state's Upper Subansari district bordering China. ... found the flower blooming in a narrow strip of rocky ...
... fitness in students. Jack O'Connell , the Superintendent of ... assessment of fifth, seventh and ninth-graders. ,The ... graders and studies student fitness in six areas. Nearly ... one-third could meet the required standards set for areas ...
Cached Medicine News:Health News:Dermatologists Provide Unique Evidence of Possible Cause of Rare Skin Condition 2Health News:Hormone Therapy May Improve the Trip Down Memory Lane 2Health News:Kidney Blood Flow May Explain Increased Long-Term Risks for Obese Kidney Donors 2Health News:Complaints Against US Federal lab Over-ruled by Panel 2Health News:Medicinal Plant Rediscovered After 115 Years 2
The DePuy ACE Titanium Active Compression Plate offers ingenuity in the art of fracture management....
Corneal Trephine Punch - Stainless steel unit with titanium jaws, complete with PTFE cutting block. 1 reusable unit....
Replacement PTFE Blocks - 5 centration holes for optimal positioning. 1 piece per box....
... almost all its mechanical strength throughout the ... 915 months. Blunt thread design assists in ... maximize surgeons options. Driver design distributes ... help prevent the screw from breaking or ...
Medicine Products: